Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on February 12, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

Awarded
NIAID-DAIDS-NIHAI2013177Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking a small business contractor to synthesize therapeutics and microbicides targeting HIV and other infectious diseases. The scope of work involves the production of chemicals for use in in vitro screens, animal testing, and early Phase I clinical studies, with a requirement for compliance with FDA current Good Manufacturing Practice regulations when necessary. This effort supports the broader goal of developing vaccines, therapeutics, and diagnostics for immune-mediated and infectious diseases. This is a 100 percent small business set-aside under NAICS 541712. The contract is structured as a cost reimbursement, term-based agreement with a one-year base period starting around February 13, 2015, and options to extend for up to six additional years. The level of effort is specified as 6.14 full-time equivalents per year for the duration of the performance period. Proposals must be submitted both via disc and through the NIAID electronic Contract Proposal Submission website.

General Info

Agency

N/A

Contract Value

$8,025,497.5

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

NY, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Notice updated

The notice description changed.

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Michelle L ScalaContracting Officer

Full Description

Show more
Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of AIDS has a requirement for the synthesis of therapeutics directed against HIV and other infectious diseases as well as agents to serve and anti-HIV topical microbicides. Description This solicitation provides the resources for the synthesis of microbicides and compounds for the treatment of HIV, and other infectious diseases of relevance to the research agenda of NIAID. The contract will synthesize chemicals, in compliance with FDA's current Good Manufacturing Practice (cGMP) regulations if necessary, in quantities needed for testing in either in vitro screens, animals, or early Phase I clinical studies. This is a 100% SMALL BUSINESS SET-ASIDE, NAICS 541712, with a size standard of 500 employees. The National Institute of Allergy and Infectious Diseases (NIAID) anticipates that one cost reimbursement, term (level of effort) type contract will be awarded for a one year base period of performance beginning on or about February 13, 2015. Options will be included to extend the term of the contract for an additional six years for a maximum period of performance of 7 years. The requirement will be for the delivery of 6.14 full time equivalents (FTEs) per year for the Base Period (Year 1) and each option period (Years 2 through 7). Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about March 6, 2014, and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. For this solicitation, the NIAID requires proposals to be submitted via two methods: (1) Disc (CD or DVD) and (2) Online via the NIAID electronic Contract Proposal Submission (eCPS) website. The content of the disc and online proposals must be identical. Submission of proposals by facsimile or e-mail is not acceptable. For directions on using eCPS, go to the website https://ecps.niaid.nih.gov and then click on "How to Submit."

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS